1. Home
  2. CDXC vs CVGW Comparison

CDXC vs CVGW Comparison

Compare CDXC & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXC
  • CVGW
  • Stock Information
  • Founded
  • CDXC 1999
  • CVGW 1924
  • Country
  • CDXC United States
  • CVGW United States
  • Employees
  • CDXC N/A
  • CVGW N/A
  • Industry
  • CDXC Medicinal Chemicals and Botanical Products
  • CVGW Specialty Foods
  • Sector
  • CDXC Health Care
  • CVGW Consumer Discretionary
  • Exchange
  • CDXC Nasdaq
  • CVGW Nasdaq
  • Market Cap
  • CDXC 546.9M
  • CVGW 517.5M
  • IPO Year
  • CDXC N/A
  • CVGW N/A
  • Fundamental
  • Price
  • CDXC $7.63
  • CVGW $27.15
  • Analyst Decision
  • CDXC Strong Buy
  • CVGW Hold
  • Analyst Count
  • CDXC 2
  • CVGW 1
  • Target Price
  • CDXC $8.00
  • CVGW $32.00
  • AVG Volume (30 Days)
  • CDXC 3.0M
  • CVGW 110.5K
  • Earning Date
  • CDXC 10-31-2024
  • CVGW 01-14-2025
  • Dividend Yield
  • CDXC N/A
  • CVGW 1.84%
  • EPS Growth
  • CDXC N/A
  • CVGW N/A
  • EPS
  • CDXC 0.02
  • CVGW N/A
  • Revenue
  • CDXC $91,668,000.00
  • CVGW $1,011,635,000.00
  • Revenue This Year
  • CDXC $18.64
  • CVGW N/A
  • Revenue Next Year
  • CDXC $20.72
  • CVGW $3.27
  • P/E Ratio
  • CDXC $388.80
  • CVGW N/A
  • Revenue Growth
  • CDXC 9.95
  • CVGW 45.46
  • 52 Week Low
  • CDXC $1.32
  • CVGW $20.30
  • 52 Week High
  • CDXC $7.85
  • CVGW $31.26
  • Technical
  • Relative Strength Index (RSI)
  • CDXC 75.32
  • CVGW 45.10
  • Support Level
  • CDXC $6.80
  • CVGW $26.61
  • Resistance Level
  • CDXC $7.67
  • CVGW $30.02
  • Average True Range (ATR)
  • CDXC 0.58
  • CVGW 0.78
  • MACD
  • CDXC 0.07
  • CVGW -0.11
  • Stochastic Oscillator
  • CDXC 91.16
  • CVGW 15.84

About CDXC ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

About CVGW Calavo Growers Inc.

Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.

Share on Social Networks: